Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5
Latuszek, Adrianna, Liu, Yashu, Olsen, Olav, Foster, Randi, Cao, Marc, Lovric, Irena, Yuan, Ming, Liu, Nina, Chen, Henry, Zhang, Qian, Xiao, Hui, Springer, Carola, Ehrlich, George, Kamat, Vishal, RafiVolume:
15
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0231892
Date:
May, 2020
File:
PDF, 1.64 MB
2020